ANNUAL REPORT - Department of Biotechnology
ANNUAL REPORT - Department of Biotechnology
ANNUAL REPORT - Department of Biotechnology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
herbaceous species (P. amarus, P. fraternus, P.<br />
debilis, P. urinaria) are more closely related to each<br />
other than other species <strong>of</strong> the same genus. P.<br />
amarus showed most similarity with P.fraternus<br />
following P.debilis and P.urinaria.<br />
Systematic and molecular taxonomic studies have<br />
been conduced in Asiatic Vigna and Macrotyloma at<br />
NBPGR, New Delhi. So far a total <strong>of</strong> 193 samples <strong>of</strong><br />
Vigna and Macrotyloma have been collected from<br />
different national and international sources. Analysis<br />
<strong>of</strong> sequence variation in rDNA regions has been<br />
completed using PCR amplification <strong>of</strong> ITS1, ITS2,<br />
26S & 18S regions. Further work on cloning and<br />
sequencing <strong>of</strong> the amplified region is in progress. In<br />
an another study at NBPGR, 153 germplasm<br />
accessions <strong>of</strong> Solanum melongena; 25 accessions <strong>of</strong><br />
S. insanum and 6 accessions <strong>of</strong> S. incanum have<br />
been collected and herbarium specimens have also<br />
been deposited at Botanical Survey <strong>of</strong> India. AFLP<br />
analysis was done for 48 accessions comprising S.<br />
melongena, S. incanum, S. viarum, S. virginianum,<br />
S. sysibriifolium, S. gilo, S. violaceum, S.<br />
acculeatissimum, S. macrocarpon and intermediate<br />
types. The AFLP data differentiated species<br />
belonging to the egg plant complex (S. melongena,<br />
S. insanium, S. incanum). The 'intermediate'<br />
accessions occupied positions among the S.<br />
melongena, S. insanum and S. incanum accessions<br />
indicating that they might be natural hybrids <strong>of</strong> these<br />
species.<br />
Animal <strong>Biotechnology</strong><br />
R&D support was continued for the development <strong>of</strong><br />
novel animal vaccines and diagnostics,<br />
characterization <strong>of</strong> indigenous breeds, development<br />
<strong>of</strong> newer reproductive techniques, utilization <strong>of</strong><br />
animal byproducts etc. A new multicentric<br />
programme on various aspects <strong>of</strong> animal nutrition<br />
was also initiated. During this period, 36 new projects<br />
were considered for financial support and so far 26<br />
projects have been funded. 14 completed and 44<br />
ongoing projects were reviewed for their outcome<br />
and successful progress. Currently, 85 projects are<br />
under implementation. Significant achievements are<br />
as follows:<br />
Animal Health Care: Vaccines and Diagnostics :<br />
The technology <strong>of</strong> large scale production <strong>of</strong><br />
recombinant protective antigen (PA) based vaccine<br />
for anthrax was developed at JNU, New Delhi and<br />
transferred to industry. Phase I / II human clinical<br />
trials <strong>of</strong> recombinant vaccine has been<br />
successfully completed. Towards developing<br />
another anthrax vaccine, lethal factor (LF) and<br />
edema factor (EF) mutants <strong>of</strong> anthrax were<br />
constructed, expressed, purified and characterized.<br />
Novel mutants <strong>of</strong> EF and LF were found to be nontoxic<br />
in vitro which provided better protective efficacy<br />
in vivo and safe to be used as vaccine component.<br />
Efforts were made to develop DNA vaccine against<br />
rabies through a multicentric project implemented at<br />
CBT, JNU, New Delhi and IVRI, Izatnagar. The RNA<br />
from rabies virus virulent strain infected mouse brain<br />
was isolated and G gene was amplified and cloned in<br />
mammalian expression vector. The<br />
immun<strong>of</strong>luorescence and immunoperoxidase tests<br />
were standardized for detection <strong>of</strong> the expression <strong>of</strong><br />
rabies virus G gene in cell culture. DNA vaccine<br />
constructs using the glycoprotein gene <strong>of</strong> rabies virus<br />
ERA strain have been developed and their potency<br />
are being studied.<br />
Molecular analysis <strong>of</strong> Indian buffalopox virus (BPXV)<br />
isolates recovered from outbreaks in both cows and<br />
buffaloes was carried out at IVRI, Mukteshwer.<br />
Sequence analysis <strong>of</strong> structural and non structural<br />
genes <strong>of</strong> BPXV showed more than 96% sequence<br />
identity (over 96%) with vaccinia virus (VACV) at the<br />
nucleotide and amino levels. PCR and PCR-RFLP<br />
based diagnostics for BPXV were devised and<br />
evaluated successfully for their diagnostic efficacy.<br />
An attenuated BPXV vaccine was developed and<br />
experimental trials in buffalo calves confirmed its<br />
safety and protection against challenge infection.<br />
Field trial <strong>of</strong> the vaccine is underway.<br />
At GBPUAT, Pantnagar, molecular characterization<br />
<strong>of</strong> fowl adenoviruses associated with<br />
Hydropericardium syndrome (HPS) and Inclusion<br />
81 Research and Development